nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—DHFR—Metabolism of folate and pterines—SLC19A1—cleft lip	0.154	0.161	CbGpPWpGaD
Trimetrexate—DHFR—One Carbon Metabolism—MTHFS—cleft lip	0.139	0.145	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—MTHFS—cleft lip	0.0701	0.0731	CbGpPWpGaD
Trimetrexate—DHFR—One Carbon Metabolism—TCN2—cleft lip	0.0515	0.0537	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism of folate and pterines—MTHFR—cleft lip	0.0474	0.0494	CbGpPWpGaD
Trimetrexate—Trimethoprim—TYMS—cleft lip	0.0418	1	CrCbGaD
Trimetrexate—DHFR—One Carbon Metabolism—MTR—cleft lip	0.0357	0.0372	CbGpPWpGaD
Trimetrexate—DHFR—G1/S-Specific Transcription—TYMS—cleft lip	0.0326	0.034	CbGpPWpGaD
Trimetrexate—DHFR—Trans-sulfuration and one carbon metabolism—MTR—cleft lip	0.0321	0.0335	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—SLC19A1—cleft lip	0.0313	0.0327	CbGpPWpGaD
Trimetrexate—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—NOS3—cleft lip	0.0263	0.0274	CbGpPWpGaD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—cleft lip	0.0251	0.0262	CbGpPWpGaD
Trimetrexate—DHFR—One Carbon Metabolism—TYMS—cleft lip	0.0219	0.0228	CbGpPWpGaD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—TCN2—cleft lip	0.0208	0.0217	CbGpPWpGaD
Trimetrexate—DHFR—Trans-sulfuration and one carbon metabolism—TYMS—cleft lip	0.0197	0.0205	CbGpPWpGaD
Trimetrexate—DHFR—E2F mediated regulation of DNA replication—TYMS—cleft lip	0.0192	0.02	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—TYMS—cleft lip	0.0192	0.02	CbGpPWpGaD
Trimetrexate—DHFR—One Carbon Metabolism—MTHFR—cleft lip	0.0191	0.0199	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism of nitric oxide—NOS3—cleft lip	0.0182	0.019	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—MTR—cleft lip	0.018	0.0188	CbGpPWpGaD
Trimetrexate—DHFR—Trans-sulfuration and one carbon metabolism—MTHFR—cleft lip	0.0172	0.0179	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—MTHFR—cleft lip	0.0168	0.0175	CbGpPWpGaD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTR—cleft lip	0.0144	0.015	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—TYMS—cleft lip	0.0102	0.0106	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—MTHFR—cleft lip	0.00962	0.01	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—TYMS—cleft lip	0.00883	0.00922	CbGpPWpGaD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cleft lip	0.00772	0.00805	CbGpPWpGaD
Trimetrexate—DHFR—G1/S Transition—TYMS—cleft lip	0.00737	0.0077	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—TYMS—cleft lip	0.00621	0.00649	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—MYC—cleft lip	0.0041	0.00428	CbGpPWpGaD
Trimetrexate—DHFR—Disease—WNT9B—cleft lip	0.00364	0.0038	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—MYC—cleft lip	0.00357	0.00372	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ABCA4—cleft lip	0.00325	0.00339	CbGpPWpGaD
Trimetrexate—DHFR—G1/S Transition—MYC—cleft lip	0.00298	0.00311	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SLC19A1—cleft lip	0.00297	0.0031	CbGpPWpGaD
Trimetrexate—DHFR—Disease—WNT3—cleft lip	0.00289	0.00302	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—MYC—cleft lip	0.00251	0.00262	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SLC19A1—cleft lip	0.00249	0.0026	CbGpPWpGaD
Trimetrexate—DHFR—Disease—TCN2—cleft lip	0.00246	0.00257	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—TYMS—cleft lip	0.00228	0.00238	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—TCN2—cleft lip	0.00206	0.00215	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—TYMS—cleft lip	0.00204	0.00213	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SPRY2—cleft lip	0.00191	0.002	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGF7—cleft lip	0.00191	0.002	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGF8—cleft lip	0.00177	0.00184	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MTR—cleft lip	0.00171	0.00178	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGF3—cleft lip	0.00144	0.0015	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MTR—cleft lip	0.00143	0.00149	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGF9—cleft lip	0.0014	0.00146	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGF10—cleft lip	0.00118	0.00123	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGFR2—cleft lip	0.000949	0.00099	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—MYC—cleft lip	0.00092	0.000961	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MTHFR—cleft lip	0.000913	0.000953	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGFR1—cleft lip	0.000884	0.000923	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—TYMS—cleft lip	0.000876	0.000914	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGFR3—cleft lip	0.000836	0.000872	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MYC—cleft lip	0.000823	0.000859	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MTHFR—cleft lip	0.000765	0.000798	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGF2—cleft lip	0.000646	0.000674	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NOS3—cleft lip	0.000637	0.000665	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NOS3—cleft lip	0.000533	0.000557	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MYC—cleft lip	0.000422	0.000441	CbGpPWpGaD
